Annual Long Term Debt
$223.01 M
-$5.17 M-2.27%
31 December 2023
Summary:
CRISPR Therapeutics AG annual long term debt is currently $223.01 million, with the most recent change of -$5.17 million (-2.27%) on 31 December 2023. During the last 3 years, it has risen by +$172.94 million (+345.42%). CRSP annual long term debt is now -2.27% below its all-time high of $228.18 million, reached on 31 December 2022.CRSP Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$210.66 M
-$4.19 M-1.95%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly long term debt is currently $210.66 million, with the most recent change of -$4.19 million (-1.95%) on 30 September 2024. Over the past year, it has dropped by -$15.92 million (-7.03%). CRSP quarterly long term debt is now -10.04% below its all-time high of $234.16 million, reached on 30 June 2022.CRSP Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | -7.0% |
| 3 y3 years | +345.4% | +9.3% |
| 5 y5 years | +100.0% | +472.0% |
CRSP Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.3% | +345.4% | -10.0% | +9.3% |
| 5 y | 5 years | -2.3% | -10.0% | +472.0% | |
| alltime | all time | -2.3% | -10.0% |
CRISPR Therapeutics AG Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $210.66 M(-2.0%) |
| June 2024 | - | $214.85 M(-1.9%) |
| Mar 2024 | - | $218.94 M(-1.8%) |
| Dec 2023 | $223.01 M(-2.3%) | $223.01 M(-1.6%) |
| Sept 2023 | - | $226.59 M(-1.6%) |
| June 2023 | - | $230.34 M(+2.6%) |
| Mar 2023 | - | $224.55 M(-1.6%) |
| Dec 2022 | $228.18 M(+7.2%) | $228.18 M(-1.2%) |
| Sept 2022 | - | $230.90 M(-1.4%) |
| June 2022 | - | $234.16 M(+2.7%) |
| Mar 2022 | - | $227.90 M(+7.1%) |
| Dec 2021 | $212.87 M | $212.87 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $192.73 M(+9.9%) |
| June 2021 | - | $175.33 M(+254.9%) |
| Mar 2021 | - | $49.41 M(-1.3%) |
| Dec 2020 | $50.07 M(+13.7%) | $50.07 M(+29.8%) |
| Sept 2020 | - | $38.57 M(-4.3%) |
| June 2020 | - | $40.32 M(-4.9%) |
| Mar 2020 | - | $42.39 M(-3.8%) |
| Dec 2019 | $44.05 M(>+9900.0%) | $44.05 M(+19.6%) |
| Sept 2019 | - | $36.83 M(-1.0%) |
| June 2019 | - | $37.20 M(+17.2%) |
| Mar 2019 | - | $31.73 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2015 | $38.34 M | $38.34 M |
FAQ
- What is CRISPR Therapeutics AG annual long term debt?
- What is the all time high annual long term debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual long term debt year-on-year change?
- What is CRISPR Therapeutics AG quarterly long term debt?
- What is the all time high quarterly long term debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly long term debt year-on-year change?
What is CRISPR Therapeutics AG annual long term debt?
The current annual long term debt of CRSP is $223.01 M
What is the all time high annual long term debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual long term debt is $228.18 M
What is CRISPR Therapeutics AG annual long term debt year-on-year change?
Over the past year, CRSP annual long term debt has changed by -$5.17 M (-2.27%)
What is CRISPR Therapeutics AG quarterly long term debt?
The current quarterly long term debt of CRSP is $210.66 M
What is the all time high quarterly long term debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly long term debt is $234.16 M
What is CRISPR Therapeutics AG quarterly long term debt year-on-year change?
Over the past year, CRSP quarterly long term debt has changed by -$15.92 M (-7.03%)